Magainin Pharm (MAGN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN)

MAGN 8.625

-2.1%

9:43 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Shlepper who wrote (142)	5/8/1998 9:06:00 AM
From: dwight martin	Read Replies (1) of 233

Schlepper- What are your thoughts on MAGN and TCLN? I got out of MAGN years ago with a small profit just before they plunged from ñ18 to ñ 1 after the first MSI-78 trial. Doing some research in MEDLINE (using the National Library of Medicine website) I noticed several abstracts concerning easy-to-make squalamine analogues that made me think MAGN's squalamine program might not be a big hit. Since MSI-78 (CytoLex) looks to be a partial fizzle, I am wondering which program you think is the reason for investing in them. Re TCLN, what do you think of their prospects for the remainder of 1998? Unlike most of the other cancer stocks, it hasn't dropped off after rising in sympathy with ENMD. I think the recent biotech flurry has caused people to take a look around, and TCLN, if believed, has some verrry interesting programs that might capture some investor attention even at high single digits, IMHO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next